In summary, our results demonstrated that Plin2 was required for induction of mitotic aberrations and cell death in different tumor entities, implying that Plin2 could be a predicting marker of susceptibility to future tumor treatments affecting SAC and to microtubule‐poisoning drugs already in clinical use. This evidence concerns the gene PLIN2 and neoplasm.